









Markets
/
Stocks
/
nasdaq-bold
/

Boundless Bio Inc

BOLD

1.080USD

-0.030-2.70%

Market hours （ET）Quotes delayed by 15 min

24.02MMarket Cap

LossP/E TTM



Boundless Bio Inc

1.080

-0.030-2.70%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Boundless Bio Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

35.06%-10.11M

23.15%-10.20M

27.14%-11.83M

7.90%-14.53M

-33.18%-15.56M

-8.84%-13.27M

-49.09%-16.24M

-30.49%-15.78M

-14.76%-11.69M

-12.86%-12.19M

---10.89M

---12.09M

---10.18M

---10.80M

Net income from continuing operations

21.66%-12.88M

15.93%-13.88M

7.66%-15.68M

-2.13%-15.76M

-35.44%-16.45M

-25.32%-16.51M

-36.93%-16.98M

-31.67%-15.43M

-3.10%-12.14M

-0.37%-13.17M

---12.40M

---11.72M

---11.78M

---13.13M

Operating gains losses

3.72%307.00K

18.32%310.00K

19.62%317.00K

20.53%317.00K

19.84%296.00K

11.49%262.00K

11.34%265.00K

10.97%263.00K

3.35%247.00K

-4.47%235.00K

--238.00K

--237.00K

--239.00K

--246.00K

Other non-cash items

205.12%308.00K

132.84%224.00K

111.65%125.00K

111.58%41.00K

43.65%-293.00K

-0.59%-682.00K

-579.11%-1.07M

-180.27%-354.00K

-201.56%-520.00K

-184.86%-678.00K

---158.00K

--441.00K

--512.00K

--799.00K

Change in working capital

173.80%831.00K

14.15%1.85M

391.48%1.71M

41.44%-927.00K

-525.56%-1.13M

197.43%1.62M

-217.17%-587.00K

4.87%-1.58M

-171.15%-180.00K

-20.47%544.00K

--501.00K

---1.66M

--253.00K

--684.00K

-Change in prepaid expenses

-42.93%569.00K

-104.91%-27.00K

63.07%-424.00K

130.53%214.00K

1045.98%997.00K

58.96%550.00K

-833.33%-1.15M

-211.56%-701.00K

-64.05%87.00K

38.96%346.00K

---123.00K

---225.00K

--242.00K

--249.00K

-Change in payables and accrued expense

147.75%977.00K

-13.62%1.54M

-3.85%1.20M

-891.90%-2.08M

-472.68%-2.05M

108.65%1.78M

7.22%1.25M

76.77%-210.00K

-1.08%549.00K

62.55%855.00K

--1.16M

---904.00K

--555.00K

--526.00K

Cash from non-recurring investing activities

Cash from operating activities

35.06%-10.11M

23.15%-10.20M

27.14%-11.83M

7.90%-14.53M

-33.18%-15.56M

-8.84%-13.27M

-49.09%-16.24M

-30.49%-15.78M

-14.76%-11.69M

-12.86%-12.19M

---10.89M

---12.09M

---10.18M

---10.80M

Investing cash flow

Net cash from continuing investing activities

-9.01%424.00K

-96.89%15.00K

-96.81%48.00K

-28.92%59.00K

73.88%466.00K

219.87%483.00K

1075.00%1.50M

-3.49%83.00K

587.18%268.00K

32.46%151.00K

--128.00K

--86.00K

--39.00K

--114.00K

Capital expenditures

-9.01%424.00K

-96.89%15.00K

-96.81%48.00K

-28.92%59.00K

73.88%466.00K

219.87%483.00K

1075.00%1.50M

-3.49%83.00K

587.18%268.00K

32.46%151.00K

--128.00K

--86.00K

--39.00K

--114.00K

Net cash flow from disposal of fixed assets

-9.01%424.00K

-96.89%15.00K

-96.81%48.00K

-28.92%59.00K

73.88%466.00K

219.87%483.00K

1075.00%1.50M

-3.49%83.00K

587.18%268.00K

32.46%151.00K

--128.00K

--86.00K

--39.00K

--114.00K

Net cash flow from investment products

485.19%13.39M

-53.60%10.49M

117.00%11.34M

-82.88%3.12M

-85.76%2.29M

398.88%22.61M

2.49%-66.69M

-18.12%18.22M

91.36%16.08M

-187.47%-7.57M

---68.39M

--22.25M

--8.40M

--8.65M

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

611.52%12.97M

-52.65%10.48M

116.56%11.29M

-83.13%3.06M

-88.47%1.82M

386.77%22.13M

0.48%-68.19M

-18.18%18.14M

89.05%15.81M

-190.41%-7.72M

---68.52M

--22.17M

--8.36M

--8.54M

Financing cash flow

Cash flow from continuous financing activities

-78.76%24.00K

100.00%0.00

-99.87%117.00K

100.00%0.00

108.16%113.00K

97.09%-13.00K

-9.08%90.65M

-3080.65%-924.00K

-4054.29%-1.38M

-1115.91%-447.00K

--99.70M

--31.00K

--35.00K

--44.00K

Net cash flow from common stock issuance/repurchase

-78.18%24.00K

100.00%0.00

-99.87%117.00K

----

--110.00K

---13.00K

--89.66M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

--99.67M

----

--0.00

Proceeds from stock option exercised by employees

----

-92.31%3.00K

-100.00%0.00

90.32%59.00K

11.43%39.00K

95.45%86.00K

--26.00K

--31.00K

--35.00K

--44.00K

Net cash flow from other financing activities

--0.00

----

--983.00K

---983.00K

---1.42M

---533.00K

----

--0.00

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-78.76%24.00K

100.00%0.00

-99.87%117.00K

100.00%0.00

108.16%113.00K

97.09%-13.00K

-9.08%90.65M

-3080.65%-924.00K

-4054.29%-1.38M

-1115.91%-447.00K

--99.70M

--31.00K

--35.00K

--44.00K

Net cash flow

Beginning cash balance

-61.89%15.54M

-52.21%15.26M

-39.01%15.68M

11.87%27.15M

89.44%40.77M

-23.77%31.92M

19.04%25.70M

111.30%24.27M

62.22%21.52M

170.38%41.88M

--21.59M

--11.48M

--13.27M

--15.49M

Current period cash flow changes

121.19%2.89M

-96.80%283.00K

-106.75%-420.00K

-898.19%-11.47M

-596.97%-13.63M

143.49%8.85M

-69.34%6.22M

-85.78%1.44M

253.70%2.74M

-816.80%-20.35M

--20.29M

--10.11M

---1.78M

---2.22M

Ending cash balance

-32.12%18.43M

-61.89%15.54M

-52.21%15.26M

-39.01%15.68M

11.87%27.15M

89.44%40.77M

-23.77%31.92M

19.04%25.70M

111.30%24.27M

62.22%21.52M

--41.88M

--21.59M

--11.48M

--13.27M

Free cash flow

34.30%-10.53M

25.74%-10.21M

33.05%-11.88M

8.01%-14.59M

-34.09%-16.03M

-11.42%-13.75M

-61.01%-17.74M

-30.25%-15.86M

-16.94%-11.95M

-13.07%-12.34M

---11.02M

---12.18M

---10.22M

---10.91M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

